Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Generate Biomedicines, Inc.
GENB
Net margin
Net margin at other companies
AutoZone
AZO
12.4%
-1.2pp
Synopsys
SNPS
8.9%
-25.9pp
Northern Trust
NTRS
22.8%
-3.9pp
Dycom Industries
DY
5%
+0.2pp
Nucor
NUE
6.8%
+2.4pp
Semtech
SMTC
-3%
—
Other financials
Income statement
See full
Revenue
$6.3M
-37.7%
Operating income
-$71.6M
-19.1%
Net income
-$67.3M
-28.3%
EPS (diluted)
-$0.52
+73.2%
Balance sheet
See full
Cash & equivalents
$135.4M
-12.3%
Total debt
$62.6M
—
Total equity
$456.0M
+188%
Total assets
$561.7M
—
Cash flow
See full
Operating cash flow
-$57.9M
-18.9%
CapEx
$933.0K
+506%
Free cash flow
-$58.9M
-20.4%
Valuation
See full
Market cap
$1.78B
+14.9%
Enterprise value
$1.71B
—
P/S
54.9×
—
Profitability
See full
Operating margin
-751.2%
—
FCF margin
-756.9%
—
Returns & leverage
See full
Return on equity
2,979.4%
—
Debt / equity
0.1×
—
Current ratio
8.3×
—
Watchlist
Screener
Filings
Earnings
Charts